The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

ad-i.net

Founded Year

2015

Stage

Series A | Alive

Total Raised

$500K

Valuation

$0000 

About AdIntelligence

AdIntelligence provides AdVisor, an online advertisement analysis and automated operation solution. The platform conducts user analysis, product information analysis, external inflow path analysis (advertisement), sales price analysis, real-time competitor search volume analysis, and KPI indicator analysis by device (PC, mobile) using its own log analysis.

AdIntelligence Headquarter Location

401 Future Cube Tower 296 Neungdong-ro, Gwangjin-gu

Seoul, 04985,

South Korea

+82 070 8650 1625

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

  • When was AdIntelligence founded?

    AdIntelligence was founded in 2015.

  • Where is AdIntelligence's headquarters?

    AdIntelligence's headquarters is located at 401 Future Cube Tower, Seoul.

  • What is AdIntelligence's latest funding round?

    AdIntelligence's latest funding round is Series A.

  • How much did AdIntelligence raise?

    AdIntelligence raised a total of $500K.

  • Who are the investors of AdIntelligence?

    Investors of AdIntelligence include VentureSquare, Seoul Techno Holdings, Korea Omega Investment Corp., Vectors and TIPS Program.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.